Skip to main content

ASCO: Ipilimumab Plus Dacarbazine Prolongs Metastatic Melanoma Survival

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
ASCO: Ipilimumab Plus Dacarbazine Prolongs Metastatic Melanoma Survival

User login

Username

Password

Reset your password

Type	Lead	score